Revised prices for 1,364 anti-cancer drug formulations take effect after margin cap on 137 drugs, with cuts of up to 96.45%
As of the evening of 9 November: the drug price regulator capped trade margins at 30% on 137 non-scheduled cancer medicines; the government estimates annual savings of Rs 3,540 crore, while India Today notes patented therapies may see less relief.